News | News By Subject | News by Disease News By Date | Search News

Leukemia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
FDA Calls Roche (RHHBY)'s Leukemia Drug a Breakthrough     7/28/2017
Roche (RHHBY) Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics     7/21/2017
3 Cancer Biotechs to Watch at ASCO     5/9/2017
Novartis AG (NVS) Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug     3/30/2017
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug     10/24/2016
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors     9/8/2016
KaloBios (KBIO) Fires Martin Shkreli, UC Davis Suspends Leukemia Trial Due to Shkreli     12/23/2015
Poland’s Selvita Stakes Out its Own Space in U.S. Pharma Hubs of Boston and San Francisco     9/18/2015
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever     8/4/2015
FDA OKs Juno (JUNO)'s IND for Lead Leukemia Candidate JCAR015     8/3/2015
Amgen (AMGN) Lauds Positive Phase II Data for Leukemia Drug Blincyto     7/17/2015
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff     5/13/2015
AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag     5/11/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015

News from Around the Web
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
2 Babies With Leukemia Are In Remission More Than A Year After Getting Treated With Gene-Edited Cells     1/27/2017
A New Antibody For Treating Acute Lymphocytic Leukemia?     12/6/2016
Small-Molecule Tool Could Reduce Leukemia Cell Regeneration, University of California, San Diego (UCSD) Study     6/13/2016
Body's Own Gene Editing System Generates Leukemia Stem Cells, University of California San Diego School of Medicine Study Reveals     6/10/2016
Untested ‘Designer Cell’ Treatment Saved One Year Old From Leukemia, Great Ormond Street Hospital Reveals     4/11/2016
Main Ingredient Of Artificial Sweetener Splenda Linked To Leukemia, Study Published In International Journal Of Occupational And Environmental Health     3/14/2016
Umbilical Blood Cells Kill Cancer Quicker Than Adult Cells, Great Ormond Street Hospital For Children Study     2/8/2016
New Way For Early Detection Of Potentially Deadly Fungal Infection In Leukemia Patients Discovered, University of Texas Medical Branch at Galveston Researchers Reveal     12/15/2015
Designer Cells Cure One-Year Old Cancer Patient, Nature Reveals     11/6/2015
Avocados May Help Fight Blood Cancer, University Of Waterloo Study     6/17/2015
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
New Drug May Be Effective Against Many Cancer Types, University College London Study     6/13/2014
Drugs To Watch: Potential Blockbusters Of 2014     4/17/2014
Mutations In Leukemia Gene Linked To New Childhood Growth Disorder, The Institute of Cancer Research Study     3/10/2014

Press Releases
The Leukemia & Lymphoma Society Announces Expansion Of Groundbreaking Precision Medicine Approach To Fight Deadly Blood Cancer     7/19/2017
FDA Advisory Committee Votes In Favor Of Pfizer (PFE)’s MYLOTARG (Gemtuzumab Ozogamicin) For Acute Myeloid Leukemia     7/12/2017
Oncoceutics Extends Patent Family To Include ONC201 In Leukemias     7/11/2017
FDA Accepts For Priority Review Bristol-Myers Squibb (BMY)’s Application For Sprycel (Dasatinib) In Children With Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia     7/10/2017
Pfizer (PFE) Release: BESPONSA Approved In The EU For Adult Patients With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia     6/30/2017
ImmunoGen (IMGN) Presents Data From Phase I Study Of IMGN779 In Acute Myeloid Leukemia     6/26/2017
Bellicum (BLCM) Reports Clinical Results Of BPX-501 In Pediatric Leukemias At The 22nd Congress Of The European Hematology Association     6/23/2017
Stemline (STML) Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association     6/23/2017
European Hematology Association: Delayed Exposure To Common Infections Causes Acute Leukemia Of Childhood     6/23/2017
European Hematology Association: The More The T-Lymphocytes Differ, The More Effectively They Fight Against Leukemia     6/23/2017
Celyad Publishes Additional Pre-Clinical Data In Support Of THINK Trial     6/21/2017
American Society of Hematology Release: Precision Therapy Enasidenib Effective in Treating Deadly Form Of Leukemia     6/7/2017
AbbVie (ABBV) Release: Long-Term IMBRUVICA (ibrutinib) Efficacy And Safety Data At ASCO 2017 Show Sustained Survival Rates In Up To Four Years In Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients, Including Those With High-Risk Disease     6/5/2017
Bristol-Myers Squibb (BMY) Release: Early, Durable Responses Seen With Sprycel (Dasatinib) In First- And Second-Line Treatment Of Pediatric Patients With Chronic Myeloid Leukemia In Chronic Phase (CP-CML)     6/5/2017
Kite Pharma (KITE) Reports 73 Percent Of Patients Achieved MRD Negative Complete Remission In Updated Analysis From Phase I ZUMA-3 CAR-T Trial Of KTE-C19 In Adult Patients With High Burden Relapsed/Refractory Acute Lymphoblastic Leukemia     6/5/2017

//-->